Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
7
×
boston blog main
boston top stories
fda
national top stories
san francisco blog main
clinical trials
san diego blog main
san diego top stories
san francisco top stories
boston
investing
ipo
seattle blog main
seattle top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
medical devices
medicare
messenger rna
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
raleigh-durham blog main
raleigh-durham top stories
startups
texas blog main
texas top stories
venture capital
What
million
7
×
therapeutics
7
×
raised
ipo
new
cancer
drug
biotech
company
developing
public
sciences
startup
treat
adding
allogene
analytics
athena
bets
bio
biofourmis
biotechs
boost
brings
ceo
chief
club
companies
continued
countouriotis
crispr
crop
data
debut
devices
digital
disorders
diversity
dyne
dyne’s
Language
unset
Current search:
million
×
" national blog main "
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M